A Kaufman Hall report for the AHA urges regulators to weigh healthcare access, hospital finances, and impacts on Medicare and Medicaid patients in merger reviews.
A Kaufman Hall report for the AHA urges regulators to weigh healthcare access, hospital finances, and impacts on Medicare and Medicaid patients in merger reviews.
Our in-brief roundup of notable healthcare and life sciences stories from the last two weeks.
The consent order mandates divestitures across five metro areas after regulators concluded the acquisition would reduce competition for key outpatient surgical services.
Companies that secretly vary prices based on how much they think individual customers will pay could be violating the FTC Act.
The agency has signaled broader interest in ensuring that companies operating in the health‑tech ecosystem maintain transparent data policies and do not engage in conduct that could disadvantage patients or healthcare providers.
The agency is the latest to drop the doctrine pursuant to a 2025 Trump executive order.
The DOJ’s Antitrust Division is returning to targeted Second Request investigations.
Federal regulators and two states claim company charged prematurely, hindered cancellations, and shared sensitive information with advertisers.